Treatment of chronic non-secretory diarrhea in ileostomy with the long-acting somatostatin analog SMS 201-995
Müller, M.K.; Breuer, N.F.; Balzer, K.; Goebell, H.
Zeitschrift für Gastroenterologie 26(3): 166-168
1988
ISSN/ISBN: 0044-2771 PMID: 2900585 Document Number: 317854
A patient with chronic refractory non-secretory diarrhea following ileostomy was treated with the long acting somatostatin analogue SMS 201-995. Under treatment with somatostatin stool weights were drastically reduced and electrolyte dysbalance was normalized within a few days. This case report shows that somatostatin is also therapeutically effective in non-secretory diarrhea.
Document emailed within 1 workday
Related Documents
Bouin, M.ël.; Aoust, L.D.' 2002: Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog Gastroenterologie Clinique et Biologique 26(10): 926-929Mystakidou, K.; Katsouda, E.; Tsilika, E.; Smyrniotis, V.; Vassiliou, I.; Tsiatas, M.; Vlahos, L. 2006: Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment Anticancer Research 26(3b): 2325-2328
Hofland, L.J. 2003: Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog Journal of Endocrinological Investigation 26(8 Suppl): 8-13
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Jurowski, P.; Goś, R.; Kunert-Radek, J. 2002: Long acting analogue of somatostatin (Octreotide) for treatment of patients with neurochorioretinitis due to ocular sarcoidosis who failed corticosteroids therapy Klinika Oczna 104(3-4): 266-269
Hofmann-Ehrhart, B.; Schulz, U.; Kluge, M.; Wandl-Vergesslich, K.; Waldhauser, F. 1995: Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth Wiener Klinische Wochenschrift 107(14): 413-417
Anthony, L.B. 1999: Long-acting formulations of somatostatin analogues Italian Journal of Gastroenterology and Hepatology 31(Suppl): S216-S218
Inagaki, A. 2016: Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option? Seishin Shinkeigaku Zasshi 118(8): 589-597
Vainas, I.; Koussis, C.; Pazaitou-Panayiotou, K.; Drimonitis, A.; Chrisoulidou, A.; Iakovou, I.; Boudina, M.; Kaprara, A.; Maladaki, A. 2004: Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma Journal of Experimental and Clinical Cancer Research: Cr 23(4): 549-559
De Bois, M.H.; Bosman, C.H.; de Graaf, P.; van Hoogenhuijze, J. 1988: Closure of a high-output external pancreatic fistula by SMS 201-995, a long-acting analogue of somatostatin Netherlands Journal of Medicine 32(5-6): 293-297
Epeirier, J.M.; Marcais, O.; Ramdani, M.; Mastour, M.; Duhamel, O.; Gislon, J. 1994: Treatment of severe gastroduodenal hemorrhages with the analog of somatostatin (octreotide: SMS 201-995) Gastroenterologie Clinique et Biologique 18(6-7): 664-665
Tulassay, Z.; Kisfalvi, K.; Papp, M. 1995: The effect of the long-acting somatostatin analogue octreotide on caerulein-induced pancreatic injuries in rats Zeitschrift für Gastroenterologie 33(2): 99-102
Wahlers, T.; Mügge, A.; Oppelt, P.; Heublein, B.; Fieguth, H.G.; Jurmann, M.; Haverich, A. 1994: Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog Transplantation Proceedings 26(5): 2741-2742
VAN DEN Heuvel, B.; Peeters, M.; Hendlisz, A.; VAN DEN Eynde, M.; Machiels, G.; Dero, I.; Geboes, K.; DE Man, M.; Hendrickx, K.; Delaunoit, T.; Monsaert, E.; Vanderstraten, E.; VAN Laethem, J.L.; Lybaert, W.; Holbrechts, S.; Rolfo, C. 2016: Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept Minerva Chirurgica 2016
Shimoda, S.; Nishida, K.; Sakakida, M.; Konno, Y.; Ichinose, K.; Uehara, M.; Nowak, T.; Shichiri, M. 1997: Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas Frontiers of Medical and Biological Engineering: the International Journal of the Japan Society of Medical Electronics and Biological Engineering 8(3): 197-211
Muranaka, T.; Yuki, S.; Komatsu, Y. 2015: Somatostatin analog Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 286-290
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
De Lecea, L. 2005: Cortistatin: a natural somatostatin analog Journal of Endocrinological Investigation 28(11 Suppl International): 10-14
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325